Published by Josh White on 22nd August 2025
(Sharecast News) - Aptamer Group reported progress across its enzyme modulation pipeline on Friday, and confirmed strong commercial validation from a top five global pharmaceutical partner, underscoring the revenue potential of its Optimer technology platform.
URL: http://www.digitallook.com/dl/news/story/35305623/...